Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
- PMID: 32125362
- PMCID: PMC7054855
- DOI: 10.1001/jama.2020.3204
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Erratum in
-
Errors in Text, Figure, and End Matter.JAMA. 2020 Apr 21;323(15):1510. doi: 10.1001/jama.2020.4372. JAMA. 2020. PMID: 32196073 Free PMC article. No abstract available.
Abstract
Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China.
Objective: To report the initial experience in Singapore with the epidemiologic investigation of this outbreak, clinical features, and management.
Design, setting, and participants: Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020.
Exposures: Confirmed SARS-CoV-2 infection.
Main outcomes and measures: Clinical, laboratory, and radiologic data were collected, including PCR cycle threshold values from nasopharyngeal swabs and viral shedding in blood, urine, and stool. Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir.
Results: Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%). Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. There were no deaths. Virus was detectable in the stool (4/8 [50%]) and blood (1/12 [8%]) by PCR but not in urine. Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results.
Conclusions and relevance: Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.
Conflict of interest statement
Figures
![Figure 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d9c/7054855/021dbec8f176/jama-323-1488-g001.gif)
![Figure 2.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d9c/7054855/25c65f021377/jama-323-1488-g002.gif)
Comment in
-
FIRST CASE OF COVID-19 IN IRELAND.Ulster Med J. 2020 Sep;89(2):128. Epub 2020 Oct 21. Ulster Med J. 2020. PMID: 33093706 Free PMC article. No abstract available.
Similar articles
-
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187464 Free PMC article. Clinical Trial.
-
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.Eur Respir J. 2020 Jul 16;56(1):2000799. doi: 10.1183/13993003.00799-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32430428 Free PMC article.
-
Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.J Korean Med Sci. 2020 Sep 21;35(37):e333. doi: 10.3346/jkms.2020.35.e333. J Korean Med Sci. 2020. PMID: 32959547 Free PMC article.
-
COVID-19 in Children: Clinical Approach and Management.Indian J Pediatr. 2020 Jun;87(6):433-442. doi: 10.1007/s12098-020-03292-1. Epub 2020 Apr 27. Indian J Pediatr. 2020. PMID: 32338347 Free PMC article. Review.
-
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. JAMA. 2020. PMID: 32648899 Review.
Cited by
-
The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis.Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100727. doi: 10.1016/j.cegh.2021.100727. Epub 2021 Mar 20. Clin Epidemiol Glob Health. 2021. PMID: 33778183 Free PMC article. Review.
-
Detection and disinfection of COVID-19 virus in wastewater.Environ Chem Lett. 2021;19(3):1917-1933. doi: 10.1007/s10311-021-01202-1. Epub 2021 Feb 22. Environ Chem Lett. 2021. PMID: 33642964 Free PMC article. Review.
-
Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia.Eur J Med Res. 2021 May 24;26(1):47. doi: 10.1186/s40001-021-00517-7. Eur J Med Res. 2021. PMID: 34030733 Free PMC article.
-
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents.Ther Adv Psychopharmacol. 2020 Jun 22;10:2045125320935306. doi: 10.1177/2045125320935306. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 32612804 Free PMC article. Review.
-
Perioperative care of the newborns with CHDs in the time of COVID-19.Cardiol Young. 2020 Jul;30(7):946-954. doi: 10.1017/S1047951120001845. Epub 2020 Jun 25. Cardiol Young. 2020. PMID: 32613934 Free PMC article.
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. Published online February 24, 2020. doi:10.1001/jama.2020.2648 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous